Clincosm LogoSign in Get a demo

Brief New Treatment for Suicide Attempts

Sponsor
University of Rochester (Other)
Overall Status
Completed
CT.gov ID
NCT03300596
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH)
34
Enrollment
1
Location
2
Arms
30.2
Actual Duration (Months)
1.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Individuals with alcohol or drug use problems who are hospitalized for suicide attempt are at high risk for reattempt. This treatment development study adapts a promising outpatient intervention to prevent suicide reattempt in order to administer it during hospitalization to individuals with alcohol and drug use problems, and to test the adapted intervention in a pilot randomized controlled trial.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Brief intervention to prevent suicide attempt
  • Behavioral: Enhanced treatment as usual
 N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Suicidal Adults With Alcohol or Drug Use Problems: A New Hospital-based Treatment
Actual Study Start Date :
Mar 12, 2018
Actual Primary Completion Date :
Sep 15, 2020
Actual Study Completion Date :
Sep 15, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: brief intervention to prevent suicide attempt

Individuals presenting to hospital following a suicide attempt who are age 18-plus and screen positive for alcohol or drug use problem

Behavioral: Brief intervention to prevent suicide attempt
A patient-centered, 3-session intervention that calls for videotaping the narrative story of a patient's suicide attempt, in his/her own words (session 1); reviewing segments of the tape to arrive at a shared understanding of the attempt and the sequence of events that led to it (session 2); and using this information, along with a homework task completed by the patient in-between sessions, in order to develop a collaborative, comprehensive written safety plan that addresses the patient's unique vulnerabilities (session 3).
Other Names:
  • Modification of the Attempted Suicide Short Intervention Program (ASSIP)

    		•
    Other: standard of care

    Individuals presenting to hospital following a suicide attempt who are age 18-plus and screen positive for alcohol or drug use problem

    Behavioral: Enhanced treatment as usual
    Safety procedures' control intervention. For these procedures we will share summary results of the research assessments regarding suicidal thoughts, suicidal behaviors, alcohol and drug use and related problems, and depressive symptoms with appropriate hospital clinical staff. We will also arrange to send this information, with participants' permission, to their ongoing therapist or treatment program and, if none exists, to the therapist or program to which they are being referred. In this regard, the research assessment protocol serves a dual function of helping with additional monitoring of high-risk patients in addition to providing data for the study.

    Outcome Measures

    Primary Outcome Measures

    1. suicide reattempt [6 months]

      number who reattempt suicide

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • suicide attempt within one week of hospitalization with acknowledgment of some intent to die using a standard item

    • problematic alcohol or drug use as determined by score >8 on Alcohol Use Disorders Identification Test, AUDIT or >3 on the 10-item version of the Drug Abuse Screening Test, DAST-10

    • admission to hospital

    • residence within 40 miles of Strong Memorial Hospital

    Exclusion Criteria:

    • under age 18

    • treated in ED, CPEP, or observation unit only

    • unable to communicate with the researcher in English

    • unable to comprehend the nature of the study

    • participation untenable from a medical (e.g., intubated), psychiatric (e.g., florid psychosis), or behavioral (e.g., refusing to speak with staff) standpoint

    • short hospital length of stay, ruling out administering three sessions of the therapy prior to discharge

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Rochester Medical Center Rochester New York United States 14642

    Sponsors and Collaborators

    • University of Rochester
    • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kenneth Conner, Professor, University of Rochester
    ClinicalTrials.gov Identifier:
    NCT03300596
    Other Study ID Numbers:
    • RSRB00069554
    First Posted:
    Oct 3, 2017
    Last Update Posted:
    Sep 17, 2020
    Last Verified:
    Sep 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Suicide
    Suicide, Attempted
    Alcohol Drinking

    Study Results

    No Results Posted as of Sep 17, 2020